2024³âµµ ´ëÇÑÅëÁõÇÐȸ Ãá°è ¿¬¼ö±³À° : 2024-05-26 |
|
2024³âµµ ´ëÇÑÅëÁõÇÐȸ Ãá°è ¿¬¼ö±³À° : 2024-05-26 ±³À°ÁÖÁ¦ : 2024³âµµ ´ëÇÑÅëÁõÇÐȸ Ãá°è ¿¬¼ö±³À° ÁÖÃÖ±â°ü : ´ëÇÑÅëÁõÇÐȸ À̸ÞÀÏ : painfree@painfree.or.kr ±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú Âü¼®¿¹»óÀÎ : 800¸í Áö¿ª : ±¤ÁÖ±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 100,000¿ø ºñ°í Àü¹®ÀÇ 100,000¿ø, ÅëÁõºÐ°úÀÎÁõÀÇ ÃëµæÀÚ 70,000¿ø, Àü°øÀÇ 40,000¿ø
±³À°½Ã°£ 05¿ù 26ÀÏ Àü½ÃȦ 08:30~09:00 Phase 3 Trials Results of ResynoONE and Its Strengths ½ÅÈ¿ë(Áß¾ÓÀÇ´ë ) ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 09:00~09:40 Mechanism and Prevention of Golf Related Injury ÀÌÇü°ï(Àü³²ÀÇ´ë) ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 09:40~10:20 Áø·á½Ç ¹Û¿¡¼ ºÁ¾ß º¸ÀÌ´Â °ñÇÁ ÅëÁõÀÇ Ä¡·á ±èµ¿Çö(¿ÂÆ®ÀçÈ°ÀÇÇаúÀÇ¿ø) Åä·Ð 05¿ù 26ÀÏ Room A 10:20~10:30 Discussion () ÈÞ½Ä 05¿ù 26ÀÏ Room A 10:30~11:00 Coffee Break () ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 11:00~11:25 Harnessing Peripheral Mu-Opioid Receptors to Combat Chemotherapy-Induced Neuropathic Pain. Vinod Tiwari(Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U), India) ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 11:25~11:50 The Crucial Role of Physical Examination for an Effective Straight to the Point of Pain Relief in Pain Management Theresia C. T. Novy(Bandung Pain Rehab Center Indonesia) ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 11:50~12:15 ¸¶¾à·ù Åõ¾à³»¿ª È®ÀÎ Àǹ«È ±èÇö¼ö(½ÄÇ°ÀǾàÇ°¾ÈÀüó ¸¶¾à°ü¸®°ú) Åä·Ð 05¿ù 26ÀÏ Room A 12:15~12:30 Discussion () ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 12:30~12:55 Neuropathic Pain Ä¡·á¿¡¼ Mirogabalin (Taleaje¢ç)ÀÇ ÀÓ»óÀû È¿´É°ú ÀÌÁ¡ ÃÖ¼º¼ö(¿ï»êÀÇ´ë) ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 13:30~13:55 °æ¸·¿Ü³»½Ã°æ ½ÃÀÛÇϱâ ÀÌÇü°ï(Àü³²ÀÇ´ë) ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 13:55~14:20 The Treatment of SEPD in Lumbar Degenerative Disease(Trans-Sacral Epiduroscopic Plasma Decompression) ÃÖÁ¾¹ü(¾ÆÁÖÀÇ´ë) ±³À°½Ã°£ 05¿ù 26ÀÏ Room A 14:20~14:45 Percutaneous Endoscopic Lumbar Annuloplasty/Neucleoplasty (PELAN) for Discongenic Pain ¹ÚÂùÈ«(´ë±¸¿ì¸®µéº´¿ø) Åä·Ð 05¿ù 26ÀÏ Room A 14:45~15:00 Discussion ()
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 825 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 765 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 771 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 627 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 992 , ´ñ±Û¼ö : 0 |